Research

Blog Post

FDA Approves PTC Therapeutics’ Emflaza for the Treatment of DMD in Patients Between 2 and 5 Years Old

By Jeanene Swanson | June 10, 2019
Blog Post

Clinical Trial Alert: Biogen Seeks Participants for a Phase 3 SOD1-ALS Study

By MDA Staff | May 30, 2019
Blog Post

Clinical Trial Alert: Alexion Pharmaceuticals Seeks Participants for a Phase 3 Pediatric Myasthenia Gravis Study

By MDA Staff | May 30, 2019
Blog Post

Do You Know ALS? Meet Dr. Cudkowicz.

By MDA Staff | May 27, 2019
Illustration of DNA
Blog Post

FDA Approves AveXis’ Zolgensma for Treatment of Spinal Muscular Atrophy in Pediatric Patients

By Jeanene Swanson | May 24, 2019
Blog Post

Do You Know ALS? Meet Dr. Glass.

By MDA Staff | May 22, 2019
Blog Post

Do You Know ALS? Meet Pat.

By MDA Staff | May 19, 2019
Blog Post

Do You Know ALS? Read About the Latest Research.

By Jeanene Swanson | May 15, 2019
Blog Post

FDA Approves Jacobus Pharmaceuticals’ Ruzurgi for Treatment of Children with Lambert-Eaton Myasthenic Syndrome

By Jeanene Swanson | May 8, 2019
Blog Post

Progress in Motion: MDA’s 2019 Clinical & Scientific Conference Heralds New Directions for Neuromuscular Disease Treatment

By MDA Staff | May 3, 2019